Q9UQF2 (JIP1_HUMAN) Homo sapiens (Human)

C-Jun-amino-terminal kinase-interacting protein 1 UniProtKBInterProSTRINGInteractive Modelling

711 aa; Sequence (Fasta)

Available Structures

27 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Crystal structure of the JIP1-JIP2-SH3 heterodimer and the JIP2-JIP2-SH3 homodimer Heteromer
Q13387;
490-547
100
Crystal structure of a cysteine-deficient mutant M7 in MAP kinase JNK1 Heteromer
P45983;
157-167
100SO4;TRS;
Crystal structure of the TPR domain of KLC1 in complex with the C-terminal peptide of JIP1 Heteromer
O88447;
701-711
100.0GOL;
Crystal Structure of JNK3 in Complex with JIP1 Peptide Heteromer
P53779;
158-167
100
Design and Synthesis of Disubstituted Thiophene and Thiazole Based Inhibitors of JNK for the Treatm… Heteromer
P53779;
158-167
100SYY;
Design and Synthesis of a Novel, Orally Efficacious Tri-substituted Thiophene Based JNK Inhibitor Heteromer
P53779;
158-167
100932;
Crystal structure of a cysteine-deficient mutant M3 in MAP kinase JNK1 Heteromer
P45983;
158-167
100SO4;GOL;
Crystal structure of a cysteine-deficient mutant M2 in MAP kinase JNK1 Heteromer
P45983;
158-167
100SO4;
Crystal structure of a cysteine-deficient mutant M1 in MAP kinase JNK1 Heteromer
P45983;
158-167
100
Crystal structure of a cysteine-deficient mutant M5 in MAP kinase JNK1 Heteromer
P45983;
158-167
100SO4;
Discovery of Potent, Highly Selective, and Orally Bioavailable Pyridine Carboxamide C-jun NH2-termi… Heteromer
P45983;
158-167
100SO4;893;GOL;
Crystal structure of a cysteine-deficient mutant M2 in MAP kinase JNK1 Heteromer
P45983;
158-167
100SO4;
Pyrazoloquinolones as Novel, Selective JNK1 inhibitors Heteromer
P45983;
158-167
100SO4;73Q;
Selective Aminopyridine-Based C-Jun N-terminal Kinase inhibitors with cellular activity Heteromer
P45983;
158-167
100SO4;877;
Crystal structure of a cysteine-deficient mutant M1 in MAP kinase JNK1 Heteromer
P45983;
158-167
100SO4;
Crystal structure of JNK1 in complex with JIP1 peptide and 4-{4-[4-(3-Methanesulfonyl-propoxy)-inda… Heteromer
P45983;
158-166
1001BK;
Crystal structure of JNK1beta-JIP in complex with an azaquinolone inhbitor Heteromer
P45983;
158-166
1000NR;
Crystal structure of JNK1 in complex with JIP1 peptide and 4-{4-[4-(4-Methanesulfonyl-piperidin-1-y… Heteromer
P45983;
158-166
1001J2;
Crystal structure of JNK1 in complex with JIP1 peptide and 4-(4-Indazol-1-yl-pyrimidin-2-ylamino)-c… Heteromer
P45983;
158-166
1001BJ;
Crystal structure of JNK1 in complex with JIP1 peptide and 7-Fluoro-3-[4-(2-hydroxy-ethanesulfonyl)… Heteromer
P45983;
158-166
100G1W;
Crystal structure of DARPin-DARPin rigid fusion, variant DD_232_11_D12 in complex JNK1a1 and JIP1 p… Heteromer
P45983;
158-166
100SO4;ADN;
SH3 domain of JNK-interacting Protein 1 (JIP1)homo-2-mer490-549
100
Mutant Y526A of SH3 domain of JNK-interacting Protein 1 (JIP1)homo-2-mer490-549
98.33PO4;1PE;EDO;PG4;
Mutant V517L of the SH3 domain of JNK-interacting protein 1 (JIP1)homo-2-mer490-549
98.33PO4;PG4;
Mutant A541L of SH3 domain of JNK-interacting Protein 1 (JIP1)homo-2-mer490-548
98.31PG4;SO4;
Mutant V517A - SH3 domain of JNK-interacting Protein 1 (JIP1)homo-2-mer490-548
98.28SO4;P6G;PO4;
Mutant H493A of SH3 domain of JNK-interacting Protein 1 (JIP1)homo-2-mer490-548
98.28PG4;GLC;

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
6itu.1.Amonomer0.63565-703
31.82